May 2024 | Report Format: Electronic (PDF)

Manufacturing Execution System in Life Sciences Market Growth & Trends

The global manufacturing execution system in life sciences market size is anticipated to reach USD 6.0 billion by 2030, registering a CAGR of 12.2% from 2024 to 2030, according to a new report by Grand View Research, Inc. The adoption of manufacturing execution system (MES) is emerging as a key factor in the life science industry, helping to improve efficiency, compliance, and innovation across production processes. In North America, MES implementation is experiencing a significant surge in the life science sector, highlighting its transformative impact on manufacturing workflows. Life science industries, including pharmaceuticals and biotechnology, require a sophisticated approach to manufacturing management. MES provides integrated and data-driven solutions that are instrumental in meeting and exceeding regulatory requirements, reducing risks, and ensuring product quality.

The growing demand for precision and quality in life science manufacturing is a key driver of market growth. MES enables companies to optimize production workflows, minimize errors, and maintain consistency in product development. Its flexibility and agility are especially valuable as the industry shifts toward personalized medicine and innovative therapies. Moreover, the prominence of Industry 4.0 technologies has bolstered the adoption of MES. Integration with the Internet of Things (IoT) and analytics creates an intelligent manufacturing ecosystem for life science manufacturers. This connectivity enables real-time monitoring, control, and data-driven decision-making, enhancing operational efficiency. Increasing demand for productivity, faster time-to-market, and superior product quality boost the adoption of MES in the life science industry. MES is becoming a central hub in the pursuit of a seamless, interconnected, and technologically advanced future in modern manufacturing.

Request a free sample copy or view report summary:
Manufacturing Execution System in Life Sciences Market Report

Manufacturing Execution System in Life Sciences Market Report Highlights

• The software solution type segment held the largest share in 2023 due to the high demand for paperless manufacturing, shift towards digitalization, and automation in manufacturing processes

• The on-premise deployment segment held the largest share in 2023 and is expected to grow at a CAGR of 11.7% from 2024 to 2030. The on-premise MES system offers ease of storing data on premises and does not rely on heavy internet, which will not hamper communication

• Such factors drive its adoption in the market. On the other hand, the cloud/web-based deployment segment is expected to grow at the fastest CAGR of 13.0% from 2024 to 2030

• The pharmaceutical & biotechnology companies end-use segment held the largest share of 48.4% in 2023. This can be attributed to the high adoption of MES in this segment owing to the shifting trend towards automation and digitalization

• North America dominated the global market with a share of 31.0% in 2023 owing to the presence of key players including Emerson Electric Co., Rockwell Automation, and Siemens AG. Asia Pacific is expected to grow at the fastest CAGR from 2024 to 2030

• Various strategies, such as product development, partnerships, and mergers & acquisitions, are adopted by key players, which is driving the market competition

• For instance, in September 2023, Körber and Endeavor partnered to facilitate the integration of Werum PAS-X MES with SAP’s ERP platform. This partnership aims to provide a seamless solution for businesses that use these two software solutions for their operations

Manufacturing Execution System in Life Sciences Market Segmentation

Grand View Research has segmented the global manufacturing execution system in life sciences market based on solution type, deployment, end-user, and region:

MES in Life Sciences Market Solution Type Outlook (Revenue, Million, 2018–2030)

• Software

• Services

MES in Life Sciences Market Deployment Outlook (Revenue, Million, 2018–2030)

• On-premise

• Cloud/Web-based

• Hybrid

MES in Life Sciences Market End-user Outlook (Revenue, Million, 2018–2030)

• Pharmaceutical & Biotechnology Companies

• Medical Device Companies

• Others (CDMOs, CROs, etc.)

List of Key Players in MES in Life Sciences Market

• ABB

• Körber AG

• MasterControl Solutions, Inc.

• AVEVA?Group Limited

• Cognizant

• Rockwell Automation

• nagarro

• Siemens AG

• Emerson Electric Co.

• iBase-t